Fujifilm Archives - Medical Design Sourcing

Fujifilm launches 2-in-1 fluoroscopy, digital radiography system

Fujifilm Healthcare Americas announced today that it began the U.S. launch of its FDR Cross hybrid c-arm and portable x-ray system.

Lexington, Massachusetts-based Fujifilm designed the FDR cross solution for hospitals and ambulatory surgery centers (ASC). The company said in a news release that the dual-function c-arm is the first of its kind to offer portable fluoroscopic and radiographic imaging on a single platform, reducing the need to bring in additional imaging equipment for essential image-guided procedures.

The platform features an innovative, pivoting tube head and removable detector design to enable greater freedom of imaging and efficiency compared to conventional configurations of a separate c-arm and mobile x-ray machine.

Additionally, the platform has compatibility with Fujifilm’s latest, ultra-lightweight, glass-free FDR D-EVO III detectors to allow configuration in 10×12, 14×17 and 17×17 inch sizes. It enables an imag…

Fujifilm to spend $1.6B to bolster cell culture manufacturing services

The multinational conglomerate Fujifilm will invest $1.6 billion to improve and ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.

Most of the investment will focus on a site in Hillerød, Denmark. A site in College Station, Texas, will also benefit from a funding injection.

The investment will increase the capacity of its cGMP batch manufacturing with the addition of eight 20,000L bioreactors and two downstream processing streams.

Fujifilm boasts that the Hillerød facility will be the largest end-to-end CDMO in Europe with 20 x 20,000L bioreactors for drug substance production.

The Denmark facility will also have sustainable production features. For example, it will use an electric boiler rather than one powered by natural gas. Fujifilm Diosynth Biotechnologies also will invest in technologies to curb water consumption.

Fujifilm expects the investment to create roughly 450 jobs. There a…

Fujifilm wins $405M DoD contract for endoscopic tech

Fujifilm Healthcare Americas Corp. recently announced a five-year U.S. Defense Department contract to provide endoscopy tech and training to all U.S. military hospitals and ambulatory surgery centers.

The contract with the U.S. Defense Logistics Agency Troop Support also covers the Veteran’s Health Administration, National Institutes of Health, Indian Health Service and more. A DoD contracts announcement from early February lists the size of the contract at $405 million.

“We are particularly honored to serve those who represent their nation so proudly in military and public service,” said Taisuke Fujita, VP of Endoscopy at Lexington, Massachusetts–based Fujifilm Healthcare Americas Corp.

“We are determined to deliver the most advanced technology to the medical teams at each of the institutions covered by this monumental agreement,” Fujita said in an April 13 news release.

The contract involves Fujifilm’s entire portfolio of endoscopic soluti…

Innovations coming out of HIMSS 2022 you should know

Companies are announcing a range of innovations in digital health, cybersecurity, AI and more at HIMSS 2022.

The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition runs March 14–18, 2022, in Orlando, Florida. It’s an annual health information and technology event where professionals can connect to learn more about innovations in the industry.

Here are some of the healthcare IT innovation announcements made at HIMSS22:

Get the full story on our sister site, Medical Design & Outsourcing.

Innovations coming out of HIMSS 2022 you should know

Companies are announcing a range of innovations in digital health, cybersecurity, AI and more at HIMSS 2022.

The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition runs March 14–18, 2022, in Orlando, Florida. It’s an annual health information and technology event where professionals can connect to learn more about innovations in the industry.

Here are some of the healthcare IT innovation announcements made at HIMSS22:

1. Philips expands medical device cybersecurity portfolio

Philips is expanding its medical device cybersecurity services to include remote access management. The new Remote Access Management Service increases uptime, clinical performance and advanced security to protect access to healthcare providers’ clinical solutions and medical devices. It combines SecureLink’s critical access management and governance technology with Philips Remove Services’ secure connectivity …

Fujifilm Sonosite files patent infringement lawsuit against Butterfly Network over handheld ultrasound

Fujifilm Sonosite announced today that it filed a patent infringement lawsuit against Butterfly Network (NYSE:BFLY).

Bothell, Washington-based Fujifilm Sonosite filed the lawsuit in the United States District Court for the District of Delaware, asserting seven patents (U.S. Patent Nos. 7,169,108; 7,867,168; 8,128,050; 8,861,822; 9,538,985; 6,901,157; and 8,360,981) pertaining to fundamental technologies for acquiring ultrasound images at the point of care with portable handheld systems.

The patents asserted by Fujifilm Sonosite cover several aspects of point of care ultrasound solutions, including the use of a probe coupled to a mobile device, elements of the graphical interface and other features related to the processing and display of ultrasound images, according to a news release.

Fujifilm Sonosite said it seeks remedies, including damages related to the alleged infringement described as Butterfly Network’s use, manufacturing, marketing, promot…

Fujifilm to aquire Atara’s T-cell manufacturing facility in California for $100M

Atara Biotherapeutics announced yesterday that Fujifilm will acquire its T-cell operations and manufacturing (ATOM) facility for $100 million.

South San Francisco-based Atara entered into a long-term strategic agreement with Fujifilm’s Diosynth Biotechnologies (FDB) subsidiary under which Fujifilm will acquire the ATOM facility in Thousand Oaks, Calif., and retain current manufacturing and quality staff at the site.

The deal also includes a long-term supply agreement that could extend to 10 years. After the transaction completes — which is expected to happen in April 2022 — FDB will provide Atara with access to the capacity and capability needed to manufacture clinical and commercial-stage allogeneic cell therapies for its pipeline. FDB will also expand the use of the manufacturing site and use its staff to manufacture a broader portfolio of cell therapies, according to a news release.

Atara’s pipeline includes tabelecleucel (tab-cel),which i…

Report: Fujifilm to expand vaccine production plant in England

Fujifilm (TSE:4901) has reportedly spent big to double the size of its United Kingdom-based vaccine manufacturing facility.

The Financial Times reported that Fujifilm is spending about $532.8 million (£400 million) to expand its Teesside (north-east England) plant that is making the Novavax COVID-19 vaccine, transforming it with factories specializing in antibody treatments and viral gene therapies.

Get the full story at our sister site, Pharmaceutical Processing World.

Fujifilm to expand vaccine production plant in England

Fujifilm (TSE:4901) has reportedly spent big to double the size of its United Kingdom-based vaccine manufacturing facility.

The Financial Times reported that Fujifilm is spending about $532.8 million (£400 million) to expand its Teesside (north-east England) plant that is making the Novavax COVID-19 vaccine, transforming it with factories specializing in antibody treatments and viral gene therapies.

According to the report, builders have already begun construction on one facility, while the land for the other remains undeveloped to this point. FT said the facilities are set to open in 2023 with up to 350 highly skilled jobs to be created in contract manufacturing.

Fujifilm manufactures the active ingredient for the vaccines developed by Novavax, FT said. Novavax’s vaccine was recently submitted to regulators, according to the report, but has not received approval in the UK, while the company said months ago that it intended to file for FDA emergenc…

Fujifilm integrates two of its medical businesses

Fujifilm Medical Systems U.S.A. and Fujifilm Healthcare Americas announced last week that the two companies have merged.

Now operating under the name Fujifilm Healthcare Americas Corporation, the new combination of organizations aims to bring together the strengths of each company’s product portfolios and employees to create new value for customers and advance medical care, according to a news release.

Henry Izawa will serve as president & CEO, with an executive management team including chairman Jun Higuchi, SVP of modality solutions John Hahn, SVP of medical informatics Bill Lacy, SVP of sales Jason Heim, SVP of regulatory & quality affairs Randy Vader, VP of endoscopy Taisuke Fujita and VP of the office of the president & CEO Takehiro Fujimoto.

“We have built a new foundation leveraging the strengths of each organization to demonstrate the clinical value and relevance of our combined portfolio,” Izawa said in the release. “Integratin…

Fujifilm picks up 10-year contract from U.S. Navy for digital radiography systems

Fujifilm Medical Systems has been awarded a long-term sole-source contract from the U.S. government for its digital radiography (DR) systems.

Lexington, Massachusetts-based Fujifilm confirmed last month that the U.S. Navy and Defense Logistics Agency (DLA) awarded it the 10-year contract to outfit Naval Fleet vessels with its DR x-ray room systems.

Fujifilm’s DR x-ray room systems include next-generation detector technology and a high-quality, compact, floor-mounted room with all of the latest features. The company anticipates the initial DR system delivery and installation will occur for a new U.S. navy ship later this year.

The Navy selected Fujifilm’s DR system on the back of a two-year evaluation and comparison with competitive technologies. The company was selected as the singular vendor that best met or exceeded the Navy’s standards and criteria, it said.

“Fujifilm is honored to be awarded this significant contract from the…

Fujifilm wins CE mark for rapid COVID-19 antigen test

Fujifilm (TSE:4901) today announced that it received CE mark approval for its antigen test kit to detect COVID-19.

The rapid diagnostic test detects SARS-CoV-2 infection. It uses the company’s silver application immunochromatography method that is based on silver amplification technology used in the photo developing process.

Fujifilm said that the antigen test is highly sensitive with the silver amplification immunochromatography method and can rapidly detect the presence of COVID-19 at an early stage and in a view of a relatively low viral load.

“During the pandemic, Fujifilm supported the global healthcare community in the complex management of the emergency,” Masaharu Fukumoto, senior VP of Fujifilms medical systems division, said in a news release. “It did so through its diagnostic and IT/AI solutions so that COVID-19 patients could be treated with the utmost care and precision. Today we can provide further support for the ear…